New Path Molecular Research
Dr Elizabeth Farrant is the CEO of New Path Molecular Research, which she founded with Prof Steven Ley and Dr Nikzad Nikbin of Cambridge University. New Path is an innovation partner in synthetic chemistry and machine assisted synthesis, developing intellectual property for its collaborators in crop science, human and animal health and fine chemicals. New Path also has its own research programs in complex functional molecule discovery for human health. Prior to New Path Elizabeth has a twenty-year track record in chemistry research and innovation, working for SmithKline Beecham, GSK and Pfizer. She has a degree in chemistry and a PhD in natural product synthesis and is a published expert in medicinal chemistry, flow chemistry, automation and lead diversification.